Commercially available wearable health monitors in dogs only had a very strong correlation during longer durations of time: a pilot study

OBJECTIVE To compare a commercially available accelerometer, FitBark 2 (FitBark 2nd Generation; FitBark) with a previously validated accelerometer, Actical (Actical; Respironics Inc) during periods of activity and rest. We hypothesized that the FitBark 2 would correlate strongly with the Actical during periods of activity and rest. METHODS 20 dogs between the ages of 1 and 9 years of variable sex, breed, and body weight were enrolled from April through August 2022 in a 1-week pilot trial. Dogs were fitted with a neck collar with both devices mounted on it and wore it continuously for 1 week. Six time points were established to evaluate varying degrees of activity and periods of rest, which included the week, a 1-mile walk, the day of the walk, the hour the walk occurred in, 6 am to 7 am on the morning of the walk, and 11 pm to 12 am on the evening of the walk. Actical and FitBark 2 were compared using linear regression and correlation analysis. RESULTS Correlation analysis revealed a very strong correlation between the Actical and FitBark 2 during the entire week of the study, with a moderate correlation at other time points. Linear regression revealed the strength of the relationship by the r 2 = 0.85, F 1,13 = 76.08. CONCLUSIONS FitBark 2 can be used to evaluate the activity and rest of dogs with varying degrees of correlation when compared to the Actical. CLINICAL RELEVANCE The time period assessed impacts the correlation of the FitBark 2 and Actical. This should be considered when using the FitBark 2 for data collection.